Publication:
DISCOVERY, STRUCTURE-ACTIVITY RELATIONSHIP STUDIES OF BENZYLIDENEACETOPHENONES AND METHOXYPHENOLS TARGETING TOLL-LIKE RECEPTOR-4 (TLR-4) AND THEIR MOLECULAR MECHANISMS IN CANCER

Simple item page
dc.contributor.authorMai Chun Wai
dc.date.accessioned2023-10-06T15:40:31Z
dc.date.available2023-10-06T15:40:31Z
dc.date.issued2014
dc.description.abstractToll-like receptor 4 (TLR-4) is recognised for its role in host innate immunity. Studies on TLR-4 over-activation had linked it to cancer survival and progression. Nevertheless, there is no TLR-4 inhibitor available for cancer treatment. Therefore, the aim of this project is to identify small molecules as TLR-4 inhibitors for cancer treatment. Computational screening methods were used to identify potential TLR-4 ligands (hits). In silico model was found to be in agreement with the results from the in vitro TLR-4 signalling assay. Lead compounds were then designed. Molecular docking reported that a potent TLR-4 inhibitor forms strong binding with both TLR-4 and myeloid differentiation 2 (MD-2). NF-κB reporter assay and Griess assay studies further confirmed these lead compounds induced potent and selective TLR-4 inhibitory effects. Immunoblotting on macrophages and HEK-BlueTM hTLR4 cells further confirmed that the most potent lead compounds, BZD3 and EP13, inhibited lipopolysaccharide (LPSEc) induced MyD88 dependent pathway, but not MyD88 independent pathway in macrophages and HEK-BlueTM hTLR-4 cells. These two lead compounds also induced potent cancer specific anti-proliferative effects and III apoptotic cell death in cancer cells. TLR-4 and MD-2 ELISA also confirmed that BZD3 and EP13 exhibited TLR-4 inhibitory effects on cancer cells by lowering the expression of TLR-4 and MD-2 levels in the cancer cells. Immunoblotting experiments supported that BZD3 and EP13 inhibited the phosphorylation of downstream MyD88 dependent and MyD88 independent pathways in cancer cells. In conclusion, this study has identified a panel of TLR-4 inhibitors that may play a role in cancer survival and progression.en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14377/32319
dc.language.isoenen_US
dc.publisherInternational Medical Universityen_US
dc.subjectToll-Like Receptor 4en_US
dc.subjectMolecular Mechanisms of Pharmacological Actionen_US
dc.subjectNeoplasmsen_US
dc.subjectStructure-Activity Relationshipen_US
dc.titleDISCOVERY, STRUCTURE-ACTIVITY RELATIONSHIP STUDIES OF BENZYLIDENEACETOPHENONES AND METHOXYPHENOLS TARGETING TOLL-LIKE RECEPTOR-4 (TLR-4) AND THEIR MOLECULAR MECHANISMS IN CANCERen_US
dc.typeThesis
dspace.entity.typePublication
Files
Original bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
230314FrontPage.pdf
Size:
318.31 KB
Format:
Adobe Portable Document Format
Description:
Front page
Download
Thumbnail Image
Name:
230314full text.pdf
Size:
17.52 MB
Format:
Adobe Portable Document Format
Description:
Final Thesis
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Plain Text
Description:
Download
Collections
Theses (PHD)